Research and Markets: Sanofi-Aventis: PharmaVitae Profile 2011 Benchmarks Sanofi-Aventis’s performance against key rivals

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/ca4091/sanofiaventis_ph) has announced the addition of the "Sanofi-Aventis: PharmaVitae Profile" report to their offering.

This analysis examines the historical and forecast performance for Sanofi-Aventis in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Gain insight into Sanofi-Aventis's strategic outlook across the next 6 years. Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source. Strategic insight into the prospects for Sanofi-Aventis over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales. Benchmark Sanofi-Aventis's performance against key rivals in the prescription pharmaceutical sector. Analyse the positioning of the company as a diversified healthcare player with an enhanced focus on the vaccine, generic and consumer markets. Assess how the genericization of blockbusters Plavix, Eloxatine, Taxotere, Stilnox/Ambien and Lovenox is expected to significantly impact growth.

Key Topics Covered:

• Executive Summary
• SWOT analysis
• ABOUT THIS PROFILE
• QUARTERLY UPDATE
• COMPANY INTRODUCTION
• COMPANY SALES
• COMPANY FINANCIALS
• KEY PRODUCTS
• APPENDIX

Companies Mentioned:

• ACS Motion Control Ltd
• AstraZeneca PLC
• Automatic Data Processing, Inc.
• Bristol-Myers Squibb Company
• Cambridge Antibody Technology Group
• CDC SPA
• Citizen Electronics Company Limited
• Eli Lilly and Company
• EMI Group PLC
• GlaxoSmithKline Plc
• IMS Health
• Insight Communications Company, Inc.
• Mayne Pharma
• Medicines Company, The
• Merck & Co., Inc.
• NICE Systems Ltd
• Novartis AG
• Novo Nordisk A/S
• Oxford BioMedica Plc
• Pfizer Inc
• Regeneron Pharmaceuticals, Inc.
• Safety Insurance Group, Inc.
• Sanofi-Aventis
• Sepracor Inc.

For more information visit http://www.researchandmarkets.com/research/ca4091/sanofiaventis_ph.

Source: Datamonitor

Research and MarketsLaura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Source: Research and Markets